Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic LymphomakinasePositive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib
Nuran Katgı, Pınar Çimen, Murat Akyol, Pınar Gürsoy, Nurşin Agüloğlu
(Thorac Res Pract 2023; 24: 180-185) DOI: 10.5152/ThoracResPract.2023.22200